GlobalData, a data and analytics company, on Tuesday said that with Type 2 diabetes accounting for the majority of cases, there is a growing demand for innovative technologies that address both diabetes and the associated condition of obesity.
As diabetes prevalence continues to rise, the medical devices industry is intensifying its focus on weight management solutions to combat the increasing global health challenge.
GlobalData forecasts that the endoscopy devices market will grow steadily due to the increasing demand for less invasive diagnostic and surgical interventions in the field of obesity.
“With the ongoing increase in Type 2 diabetes, it is imperative to recognize the critical role of weight management in disease prevention and control. The medical devices industry is responding with innovative solutions that not only address diabetes but also tackle the underlying issue of obesity. These developments are key to managing the growing global diabetes burden,” Alexandra Murdoch, Senior Medical Analyst at GlobalData, said.
Against this backdrop, Fractyl Health, a metabolic therapeutics company, has recently reported positive outcomes for its hydrothermal ablation device, Revita. The device, which resurfaces the mucosal lining of the duodenum, has shown promise in reducing the need for medications in patients with Type 2 diabetes.
This breakthrough represents a growing trend in the medical devices industry, where companies are increasingly focusing on weight management technologies as a complementary strategy for diabetes care.
“As we witness the rise of Type 2 diabetes, it is encouraging to see the medical devices industry stepping up with innovative weight management solutions. Maintaining a healthy weight is crucial for reducing the risk of diabetes, and these advancements are essential in our fight against this chronic disease,” Murdoch said.